Cell Culture and Tissue Engineering
Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples
Article first published online: 7 MAR 2013
DOI: 10.1002/btpr.1698
Copyright © 2013 American Institute of Chemical Engineers
Additional Information
How to Cite
Kasturirangan, S., Reasoner, T., Schulz, P., Boddapati, S., Emadi, S., Valla, J. and Sierks, M. R. (2013), Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples. Biotechnol Progress, 29: 463–471. doi: 10.1002/btpr.1698
Publication History
- Issue published online: 5 APR 2013
- Article first published online: 7 MAR 2013
- Accepted manuscript online: 28 JAN 2013 11:05PM EST
- Manuscript Revised: 17 JAN 2013
- Manuscript Received: 31 OCT 2012
Funded by
- Arizona Department of Health Services
- National Institute on Aging. Grant Number: P30 AG19610
- Arizona Department of Health Services. Grant Number: 211002
- Arizona Alzheimer's Research Center
- the Arizona Biomedical Research Commission. Grant Numbers: 4001, 0011, 05–901, 1001
- Prescott Family Initiative of the Michael J. Fox Foundation
- Abstract
- Article
- References
- Cited By
Keywords:
- biopanning;
- single-chain antibody fragments;
- antibody libraries;
- beta-amyloid;
- oligomeric aggregates;
- nanotechnology;
- atomic force microscopy
We developed atomic force microscope (AFM)-based protocols that enable isolation and characterization of antibody-based reagents that selectively bind target protein variants using low nanogram amounts or less of unpurified starting material. We isolated single-chain antibody fragments (scFvs) that specifically recognize an oligomeric beta-amyloid (Aβ) species correlated with Alzheimer's disease (AD) using only a few nanograms of an enriched but not purified sample obtained from human AD brain tissue. We used several subtractive panning steps to remove all phage binding nondesired antigens and then used a single positive panning step using minimal antigen. We also used AFM to characterize the specificity of the isolated clones, again using minimal material, selecting the C6 scFv based on expression levels. We show that C6 selectively binds cell and brain-derived oligomeric Aβ. The protocols described are readily adapted to isolating antibody-based reagents against other antigenic targets with limited availability. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 463–471, 2013

1520-6033/asset/BTPR_left.gif?v=1&s=a5be2ff5a0fe6ccdaad74a6d128c142e5f71a8da)
1520-6033/asset/BTPR_right.gif?v=1&s=992d113a3e61fc9d3571812359165df86cf830e4)
